Letts,
I wouldn't be too disappointed with AHZ.
It will turn out a pretty good rights issue IMO. It might not suit the short-termers on HC, but you will be ahead when all is said and done and you take up the rights. I had sold a few, but I bought them all back this morning and am happy to have done so.
The current buyers and sellers lists in ECQ will change dramatically after the announcement and depending on the tone, which is likely to to be good and likely to entail buying out Cyanata(and with luck a name change).
As it is being financed with shares, it may cause some ongoing cost analysis as ECQ would be responsible for 100% of costs, but of course they get 100 of profits and that will lift the share price, but probably not through the roof (at least for the time being)......
- Forums
- ASX - By Stock
- stem cells-the next boom
Letts,I wouldn't be too disappointed with AHZ. It will turn out...
Featured News
Add ECQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NXD
NEXTED GROUP LIMITED
Nick Poll, Managing Director
Nick Poll
Managing Director
SPONSORED BY The Market Online